Indacaterol and Glycopyrrolate and Insulin glargine and lixisenatide Subcutaneous
Determining the interaction of Indacaterol and Glycopyrrolate and Insulin glargine and lixisenatide Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: glycopyrrolate / indacaterol
Brand name: Utibron Neohaler
Synonyms: Glycopyrrolate and indacaterol (inhalation)
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Indacaterol and Glycopyrrolate-Insulin glargine, recombinant Subcutaneous
- Indacaterol and Glycopyrrolate-Insulin glulisine
- Indacaterol and Glycopyrrolate-Insulin Glulisine (Cartridges and Pens)
- Indacaterol and Glycopyrrolate-Insulin Glulisine (Vials)
- Indacaterol and Glycopyrrolate-Insulin glulisine Subcutaneous
- Indacaterol and Glycopyrrolate-Insulin human inhaled Inhalation
- Insulin glargine and lixisenatide Subcutaneous-Indacaterol and glycopyrrolate Inhalation
- Insulin glargine and lixisenatide Subcutaneous-Indacaterol inhalation
- Insulin glargine and lixisenatide Subcutaneous-Indacaterol Maleate
- Insulin glargine and lixisenatide Subcutaneous-Indapamide
- Insulin glargine and lixisenatide Subcutaneous-Inderal
- Insulin glargine and lixisenatide Subcutaneous-Inderal Intravenous